MODN - Model N launches SaaS solution for pharma biotech firms for price transparency reporting
Model N (NYSE:MODN) announced its new SaaS solution for pharmaceutical and biotech companies, designed to meet the demands for state price transparency mandates. With this new solution, MODN will deliver State Price Transparency Management (NYSEARCA:SPTM), the first SaaS solution built specifically to assist pharmaceutical and biotech firms in operationalizing the end-to-end process to meet evolving state mandates. SPTM capabilities will ensure that MODN customers can meet state-by-state price transparency requirements, managing compliance while simultaneously facilitating complete traceability and standardization.
For further details see:
Model N launches SaaS solution for pharma, biotech firms for price transparency reporting